Display Settings:

Format

Send to:

Choose Destination
    Oral Surg Oral Med Oral Pathol. 1993 Feb;75(2):156-64.

    Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication.

    Source

    Clinical Pharmacology Unit, National Institute for Dental Research, National Institutes of Health, Bethesda, Md.

    Abstract

    Triazolam was evaluated as an oral sedative agent for dental outpatients in two studies in the oral surgery model. The first study demonstrated that 0.25 mg of triazolam in combination with nitrous oxide provides therapeutic effects but with a more rapid recovery than a 0.50 mg dose in combination with nitrous oxide. In the second study, triazolam produced a significant anxiolytic effect that was comparable to the effects of diazepam titrated to the usual clinical endpoint (mean dose = 19.3 mg). Less impairment in cognitive-psychomotor impairment and ambulatory function was seen after triazolam in comparison with diazepam. Triazolam appears to be a safe, effective alternative to parenteral sedation with a benzodiazepine for dental outpatients.

    PMID:
    8426714
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk